albendazole has been researched along with Vaginal Diseases in 1 studies
Vaginal Diseases: Pathological processes of the VAGINA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hendrixson, DT | 1 |
| Smith, K | 1 |
| Lasowski, P | 1 |
| Callaghan-Gillespie, M | 1 |
| Weber, J | 1 |
| Papathakis, P | 1 |
| Iversen, PO | 1 |
| Koroma, AS | 1 |
| Manary, MJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized Control Trial of the Use of Supplementary Food and Measures to Control Inflammation in Malnourished Pregnant Women to Improve Birth Outcomes[NCT03079388] | 1,489 participants (Actual) | Interventional | 2017-02-27 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for albendazole and Vaginal Diseases
| Article | Year |
|---|---|
A novel intervention combining supplementary food and infection control measures to improve birth outcomes in undernourished pregnant women in Sierra Leone: A randomized, controlled clinical effectiveness trial.
Topics: Adolescent; Adult; Albendazole; Anti-Bacterial Agents; Antiprotozoal Agents; Azithromycin; Dysbiosis | 2021 |